Gut Microbiota—A Future Therapeutic Target for People with Non-Alcoholic Fatty Liver Disease: A Systematic Review

Non-alcoholic fatty liver disease (NAFLD) represents an increasing cause of liver disease, affecting one-third of the population worldwide. Despite many medications being in the pipeline to treat the condition, there is still no pharmaceutical agent licensed to treat the disease. As intestinal bacte...

Descripción completa

Detalles Bibliográficos
Autores principales: Forlano, Roberta, Sivakumar, Mathuri, Mullish, Benjamin H., Manousou, Pinelopi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368436/
https://www.ncbi.nlm.nih.gov/pubmed/35955434
http://dx.doi.org/10.3390/ijms23158307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368436/
https://www.ncbi.nlm.nih.gov/pubmed/35955434
http://dx.doi.org/10.3390/ijms23158307

Ejemplares similares